Unless otherwise defined, all abbreviations used herein shall have the same meaning as those defined in the Company’s announcements dated 10 May 2024, 14 May 2024, 30 September 2024, 8 January 2025 and 14 January 2025 in relation to the Proposed Transfer of Listing (“Announcements”).

Reference is made to the Announcements.

On behalf of the Board, M&A Securities wishes to announce that Bursa Securities had, vide its letter dated 11 March 2025, resolved to approve the application for the Proposed Withdrawal.

In this regard, M&A Securities is required to furnish Bursa Securities with a letter (“M&A Securities’ Confirmation Letter”), confirming the following:

(i) that all subsisting undertaking letters provided by the shareholders of Fibromat remain valid and enforceable as at the date of M&A Securities’ Confirmation Letter until the completion of the Proposed Transfer of Listing;

(ii) that the requirements of Rule 8.06(1) of the LMLR have been complied with or waived by Bursa Securities, as the case may be;

(iii) that all conditions, including conditions imposed by the relevant authorities which as required to be met prior to the delisting have been met; and

(iv) that there are no circumstances or facts which have the effect of preventing or prohibiting the delisting including any order, injunction or any other directive issued by any court of law.

Further, Fibromat is required to announce, 5 clear markets days before the effective date of suspension, the following:

(i) the trading in Fibromat Shares on the LEAP Market will be suspended one market day before the date of allotment of the new Fibromat Shares to be issued pursuant to the Proposed Listing until the completion of the Proposed Listing; and

(ii)  the effective date of suspension.

The delisting of Fibromat will take place after trading in Fibromat Shares has been suspended.

This announcement is dated 12 March 2025.